At a glance
ClinicalIndex Comparison RecordN/ACompleted· 138 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational, Cross-sectional, Longitudinal, Multi-center, Diagnostic Study to Evaluate the Influence of Acromegaly on Glucose Tolerance and to Evaluate the Changes of Impaired Glucose Tolerance During Standard Treatment of Acromegaly.
In Brief
An observational study for Acromegaly and 3 related conditions. Completed, enrolled 138 participants across 6 sites.
Detailed Summary
Observational, Cross-sectional, longitudinal, multi-center, diagnostic study Cross-sectional part of the study: To evaluate the influence of acromegaly on glucose tolerance Longitudinal part of the study: To evaluate the changes of impaired glucose tolerance during standard treatment of acromegaly. Adult patients with established acromegaly Cross-sectional part of the study: 150 patients Longitudinal part of the study: 58 patients
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcromegaly, Diabetes, Insulin Resistance, Impaired Glucose Tolerance
CountriesGermany
CollaboratorsPfizer, Ludwig-Maximilians - University of Munich
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2008
Primary CompletionApr 2011
Study CompletionDec 2012
TodayJul 2026
First PostedApr 21, 2008
Enrollment StartApr 1, 2008
Primary CompletionApr 1, 2011
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 18.2 years ago